Review article · 1 Nov 2021
Conference abstractPublished 3 Aug 2015
A review on autism
Jayoti Vidya Peeth WomensâÂ?Â? University, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Autism is a congenital neurological disorder characterized by impairment of socialization, abnormalities of communication, limited activity and curiosity. Clinical signs of Autism Spectrum Disorders (ASD) are frequently presented at 3 years of age with abnormalities in social, communication and play behaviour, though early indicators of autism can be detected as early as 14 months of age. Repetitive, stereotyped, and obsessive compulsiveâÂ?Â?like behaviours are also prominent features of the disorder and are often accompanied by cognitive impairment, seizures or epilepsy, gastrointestinal complaints, disordered sleep, and others are frequent problems in the clinical profiles of patients with autism. There are certain factors that contribute to the pathogenesis of ASD, such as dysfunctions of the serotonergic system, have been implicated in autism. The serotonergic system appears to be developmentally dis-regulated in autism. The study suggested that the clinical onset of autism appears to be preceded by two phases of brain growth abnormalities: a reduced head size at birth, then a sudden and excessive increase between 1âÂ?Â?2 months and 6âÂ?Â?14 months of age. Neuroimaging studies have shown that an abnormal pattern of brain overgrowth also occurs in areas of the frontal lobe, cerebellum and limbic structures between 2 and 4 years of age, a pattern that is followed by abnormal slowness in brain growth. Another study revealed that the oxidative stress might be unregulated in patients with ASDs, possibly due to decreased ability to neutralize free radicals. One study of autistic children and controls reported that plasma S âÂ?Â?adenosyl homocysteine, which was used as an indicator of methylation ability, was significantly lower in autistic children. Another study found reduced plasma levels of the key endogenous antioxidant SâÂ?Â?adenosyl methionine. Other reviews suggested that the Erythrocyte Superoxide Dismutase (SOD) and the endogenous antioxidants plasma glutathione peroxidase and erythrocyte glutathione peroxidase (GSH-Px) were also significantly reduced in autistic children. Increased mitochondrial metabolism and oxidized mitochondrial proteins in temporo-cortical gray matter in postmortem samples from autistic patients as compared to controls was also seen. Calcitriol down-regulates production of inflammatory cytokines in the brain, which have been associated with autism. Vitamin D deficiency impairs glutathione metabolism, which may explain the link between autism and oxidative stress, as well as autism and mercury accumulation. Consumption of vitamin D containing fish during pregnancy reduces autistic symptoms in children. It seems probable that autismâÂ?Â?s neuro-developmental defect is âÂ?Â?multi-domainâÂ?Â? in origin (rather than a single anomaly) and is, hence, distributed across numerous levels of study (genetic, immunepathogenic, etc.). A more definitive understanding of the pathogenesis could facilitate the development of better treatments for this complex psychiatric disorder.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 6 Oct 2025
Early biomarkers for autism spectrum disorder: A systematic review of diagnostic advances in early childhood
Conference abstract · 22 May 2025
Structural Insights into Protein Mutations Related to Autism Spectrum Disorders: A Systematic Review
Conference abstract · 22 May 2025
Parental Stress and Behavioral Outcomes in Children with Autism Spectrum Disorder: A Systematic Review
Article · 12 May 2025
Investigating the parenting style of parents of children with autism spectrum disorder: A systematic review article
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Juhi Tiwari”
- BylineArticles whose byline prints “Smriti Rai”

